Has Nathaniel Vanvalin, PA received payments from drug or device companies?

Yes. Drug and device makers reported $294 in general payments to Nathaniel Vanvalin, PA across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nathaniel Vanvalin, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nathaniel Vanvalin, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nathaniel Vanvalin, PA

Medical · Post Falls, IDNPI 1386821759

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for medical clinicians in ID, where the typical reported total is $367.

$294in general payments, 2019–2025

Across 16 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$62
Exact Sciences$54
AstraZeneca$49
Lilly USA, LLC$37
Amgen$22
Phathom Pharmaceuticals, Inc.$21
plus $49 from 3 others

What the payments were for

Food & beverage$294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	1	$62
Exact Sciences	2	$54
AstraZeneca	3	$49
Lilly USA, LLC	2	$37
Amgen	1	$22
Phathom Pharmaceuticals, Inc.	4	$21
Pfizer	1	$19
Novo Nordisk	1	$15
AbbVie	1	$14

How this compares

$294 in reported general payments places this provider in the 40th percentile of 265 medical providers in Idaho.

See all medical providers in Idaho →

Medicare billing

Part B allowed, 2024

$38,166

Medicare patients

441

Services billed

511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	56	$583
Cephalexin	75	$563
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	55	$489
Albuterol Sulfate HfaAlbuterol Sulfate	21	$344
Diclofenac Sodium	15	$110
Ciprofloxacin Hcl	13	$99
Prednisone	60	$87
Azithromycin	20	$82
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	18	$45
Tizanidine Hcl	14	$45
Meloxicam	11	$19

Paid to pharmacies, not to this prescriber.